Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

@article{Newcorn2008AtomoxetineAO,
  title={Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.},
  author={Jeffrey H. Newcorn and Christopher J. Kratochvil and Albert J. Allen and Charles D Casat and Dustin D Ruff and Rodney J Moore and D. Michelson},
  journal={The American journal of psychiatry},
  year={2008},
  volume={165 6},
  pages={721-30}
}
OBJECTIVE Response to atomoxetine, a nonstimulant norepinephrine-specific reuptake inhibitor, was compared with the effect of osmotic-release oral methylphenidate, a long-acting methylphenidate preparation, in patients with attention deficit hyperactivity disorder (ADHD). METHOD In a large placebo-controlled, double-blind study, patients ages 6-16 with ADHD, any subtype, were randomly assigned to receive 0.8-1.8 mg/kg per day of atomoxetine (N=222), 18-54 mg/day of osmotically released… CONTINUE READING
Highly Influential
This paper has highly influenced 17 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS